Opportunities Preloader

Please Wait.....

Report

Diabetic Foot Ulcers Market Report and Forecast 2024-2032

Market Report (7 days) I 2024-02-09 I 140 Pages I EMR Inc.

Diabetic Foot Ulcers Market Report and Forecast 2024-2032
Diabetic Foot Ulcers Market Outlook
The diabetic foot ulcers market size was valued at USD 6.32 billion in 2023, driven by increasing prevalence of diabetes. The market size is anticipated to grow at a CAGR of 5.85% during the forecast period of 2024-2032 to achieve a value of USD 10.5 billion by 2032.
Diabetic Foot Ulcers: Introduction
Diabetic foot ulcers are open sores or wounds that occur in approximately 15% of patients with diabetes and commonly develop on the bottom of the foot. They are a major complication of diabetes, resulting from a combination of factors, including poor circulation, neuropathy (nerve damage), foot deformities, and pressure or friction. These ulcers can become serious if not treated promptly, as they may lead to infections and, in severe cases, amputation.
Key Trends in the Diabetic Foot Ulcers Market
Globally, the increasing prevalence of diabetes due to sedentary lifestyles, obesity, and aging populations is leading to a higher incidence of diabetic foot ulcers. This trend is prompting a growing demand for effective treatment options and is driving research and development in this field.
There is a significant trend towards the adoption of advanced wound care products, including biologics, skin substitutes, and advanced dressings. These technologies are designed to promote faster healing, reduce the risk of infection, and improve patient outcomes.
There's an increasing emphasis on a multidisciplinary approach to diabetic foot ulcer management, involving specialists such as diabetologists, podiatrists, wound care experts, and nutritionists. This comprehensive care model aims to address all aspects of the condition, from blood sugar control to local wound care.
The demand for home healthcare services for diabetic foot ulcer treatment is growing, driven by patient preference for receiving care in the comfort of their homes. Home healthcare is also seen as a cost-effective alternative to hospital stays.
Telemedicine and remote monitoring are becoming increasingly important in managing diabetic foot ulcers, especially in rural or underserved areas. These technologies allow for regular monitoring of ulcers, timely intervention, and better patient education, improving overall patient management.
Governments and non-governmental organizations worldwide are initiating programs to raise awareness about diabetes and its complications, including diabetic foot ulcers. These initiatives often provide education, resources, and support to improve prevention, early detection, and management of diabetic foot ulcers.
Diabetic Foot Ulcers Market Segmentation
Market Breakup by Product Type
- Biologics
- Wound Care Dressings
Market Breakup by Type
- Neuro-ischemic
- Ischemic
- Neuropathic
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
- Others
Market Breakup by End User
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
o Germany
o France
o Italy
o Spain
o United Kingdom
- Japan
Diabetic Foot Ulcers Market Overview
North America, particularly the United States, shows a proactive approach to DFU management, marked by advanced healthcare facilities, a high standard of care, and significant investments in research and development. There is a strong emphasis on early detection and comprehensive treatment, including innovative wound care products and therapies. Public awareness campaigns and diabetes education programs also contribute to market dynamics.
Europe demonstrates a strong commitment to diabetes management and DFU treatment, supported by well-established healthcare systems and public health initiatives. The region sees a steady adoption of advanced wound care products, driven by a focus on reducing hospital stays and promoting cost-effective treatment options. European countries also have stringent regulations ensuring the quality and efficacy of medical products, influencing the DFU market landscape.
Japan is experiencing rapid growth in the DFU market, propelled by a rising diabetic population, increasing healthcare expenditure, and growing awareness of advanced wound care solutions. Countries like China, India, and Japan are investing in healthcare infrastructure improvement and diabetes management programs. However, there is considerable variation in access to advanced DFU treatments across different countries in the region.
Diabetic Foot Ulcers Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- ConvaTec, Inc.
- Acelity L.P., Inc
- 3M Healthcare
- Coloplast Corp.
- Smith & Nephew Plc
- B Braun Melsungen AG
- Medline Industries, Inc.
- Organogenesis, Inc.
- Molnlycke Health Care AB
- Medtronics
- Kerecis
- Essity Aktiebolag AB
- Tissue Regenix
- Integra Lifesciences
- Cardinal Health

We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Diabetic Foot Ulcers Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Diabetic Foot Ulcers Epidemiology Analysis - 7MM
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.1 Germany Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.2 France Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.3 Italy Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.4 Spain Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.4 Japan Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
6 Diabetic Foot Ulcers Market Overview - 7MM
6.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
6.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
7 Diabetic Foot Ulcers Market Landscape - 7MM
7.1 Diabetic Foot Ulcers Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Diabetic Foot Ulcers Product Landscape
7.2.1 Analysis by Products
7.2.2 Analysis by Type
7.2.3 Analysis by Route of Administration
8 Diabetic Foot Ulcers Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Diabetic Foot Ulcers Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter's Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Diabetic Foot Ulcers Market Segmentation - 7MM
11.1 Diabetic Foot Ulcers Market by Product Type
11.1.1 Market Overview
11.1.2 Biologics
11.1.3 Wound Care Dressings
11.2 Diabetic Foot Ulcers Market by Type
11.2.1 Market Overview
11.2.2 Neuro-ischemic
11.2.3 Ischemic
11.2.4 Neuropathic
11.2.5 Others
11.3 Diabetic Foot Ulcers Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Parenteral
11.3.4 Others
11.4 Diabetic Foot Ulcers Market by End User
11.4.1 Market Overview
11.4.2 Hospital Pharmacy
11.4.3 Online Pharmacy
11.4.4 Retail Pharmacy
11.5 Diabetic Foot Ulcers Market by Region
11.5.1 Market Overview
11.5.2 United States
11.5.3 EU-4 and the United Kingdom
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 Italy
11.5.3.4 Spain
11.5.3.5 United Kingdom
11.5.4 Japan
12 United States Diabetic Foot Ulcers Market
12.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
12.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
12.3 Diabetic Foot Ulcers Market by Disease Type
12.4 Diabetic Foot Ulcers Market by Treatment Type
13 EU-4 and United Kingdom Diabetic Foot Ulcers Market
13.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
13.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
13.3 Germany Diabetic Foot Ulcers Market Overview
13.3.1 Diabetic Foot Ulcers Market by Disease Type
13.3.2 Diabetic Foot Ulcers Market by Treatment Type
13.4 France Diabetic Foot Ulcers Market Overview
13.4.1 Diabetic Foot Ulcers Market by Disease Type
13.4.2 Diabetic Foot Ulcers Market by Treatment Type
13.5 Italy Diabetic Foot Ulcers Market Overview
13.5.1 Diabetic Foot Ulcers Market by Disease Type
13.5.2 Diabetic Foot Ulcers Market by Treatment Type
13.6 Spain Diabetic Foot Ulcers Market Overview
13.6.1 Diabetic Foot Ulcers Market by Disease Type
13.6.2 Diabetic Foot Ulcers Market by Treatment Type
13.7 United Kingdom Diabetic Foot Ulcers Market Overview
13.7.1 Diabetic Foot Ulcers Market by Disease Type
13.7.2 Diabetic Foot Ulcers Market by Treatment Type
14 Japan Diabetic Foot Ulcers Market
14.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
14.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
14.3 Diabetic Foot Ulcers Market by Disease Type
14.4 Diabetic Foot Ulcers Market by Treatment Type
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Grants Analysis
16.1 Analysis by year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Application
16.5 Analysis by Funding Institute
16.6 Analysis by NIH Departments
16.7 Analysis by Recipient Organization
17 Clinical Trials Analysis
17.1 Analysis by Trial Registration Year
17.2 Analysis by Trial Status
17.3 Analysis by Trial Phase
17.4 Analysis by Therapeutic Area
17.5 Analysis by Geography
18 Funding Analysis
18.1 Analysis by Funding Instances
18.2 Analysis by Type of Funding
18.3 Analysis by Funding Amount
18.4 Analysis by Leading Players
18.5 Analysis by Leading Investors
18.6 Analysis by Geography
19 Partnership and Collaborations Analysis
19.1 Analysis by Partnership Instances
19.2 Analysis by Type of Partnership
19.3 Analysis by Leading Players
19.4 Analysis by Geography
20 Supplier Landscape
20.1 ConvaTec, Inc.
20.1.1 Financial Analysis
20.1.2 Product Portfolio
20.1.3 Demographic Reach and Achievements
20.1.4 Mergers and Acquisition
20.1.5 Certifications
20.2 Acelity L.P., Inc
20.2.1 Financial Analysis
20.2.2 Product Portfolio
20.2.3 Demographic Reach and Achievements
20.2.4 Mergers and Acquisition
20.2.5 Certifications
20.3 3M Healthcare
20.3.1 Financial Analysis
20.3.2 Product Portfolio
20.3.3 Demographic Reach and Achievements
20.3.4 Mergers and Acquisition
20.3.5 Certifications
20.4 Coloplast Corp.
20.4.1 Financial Analysis
20.4.2 Product Portfolio
20.4.3 Demographic Reach and Achievements
20.4.4 Mergers and Acquisition
20.4.5 Certifications
20.5 Smith & Nephew Plc
20.5.1 Financial Analysis
20.5.2 Product Portfolio
20.5.3 Demographic Reach and Achievements
20.5.4 Mergers and Acquisition
20.5.5 Certifications
20.6 B Braun Melsungen AG
20.6.1 Financial Analysis
20.6.2 Product Portfolio
20.6.3 Demographic Reach and Achievements
20.6.4 Mergers and Acquisition
20.6.5 Certifications
20.7 Medline Industries, Inc.
20.7.1 Financial Analysis
20.7.2 Product Portfolio
20.7.3 Demographic Reach and Achievements
20.7.4 Mergers and Acquisition
20.7.5 Certifications
20.8 Organogenesis, Inc.
20.8.1 Financial Analysis
20.8.2 Product Portfolio
20.8.3 Demographic Reach and Achievements
20.8.4 Mergers and Acquisition
20.8.5 Certifications
20.9 Molnlycke Health Care AB
20.9.1 Financial Analysis
20.9.2 Product Portfolio
20.9.3 Demographic Reach and Achievements
20.9.4 Mergers and Acquisition
20.9.5 Certifications
20.10 Medtronics
20.10.1 Financial Analysis
20.10.2 Product Portfolio
20.10.3 Demographic Reach and Achievements
20.10.4 Mergers and Acquisition
20.10.5 Certifications
20.11 Kerecis
20.11.1 Financial Analysis
20.11.2 Product Portfolio
20.11.3 Demographic Reach and Achievements
20.11.4 Mergers and Acquisition
20.11.5 Certifications
20.12 Essity Aktiebolag AB
20.12.1 Financial Analysis
20.12.2 Product Portfolio
20.12.3 Demographic Reach and Achievements
20.12.4 Mergers and Acquisition
20.12.5 Certifications
20.13 Tissue Regenix
20.13.1 Financial Analysis
20.13.2 Product Portfolio
20.13.3 Demographic Reach and Achievements
20.13.4 Mergers and Acquisition
20.13.5 Certifications
20.14 Integra Lifesciences
20.14.1 Financial Analysis
20.14.2 Product Portfolio
20.14.3 Demographic Reach and Achievements
20.14.4 Mergers and Acquisition
20.14.5 Certifications
20.15 Cardinal Health
20.15.1 Financial Analysis
20.15.2 Product Portfolio
20.15.3 Demographic Reach and Achievements
20.15.4 Mergers and Acquisition
20.15.5 Certifications
21 Diabetic Foot Ulcers Market - Distribution Model (Additional Insight)
21.1 Overview
21.2 Potential Distributors
21.3 Key Parameters for Distribution Partner Assessment
22 Key Opinion Leaders (KOL) Insights (Additional Insight)
23 Company Competitiveness Analysis (Additional Insight)
23.1 Very Small Companies
23.2 Small Companies
23.3 Mid-Sized Companies
23.4 Large Companies
23.5 Very Large Companies
24 Payment Methods (Additional Insight)
24.1 Government Funded
24.2 Private Insurance
24.3 Out-of-Pocket

*Additional insights provided are customisable as per client requirements.

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE